Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,046Revenue $M4.1Net Margin (%)-3,372.4Z-Score59.5
Enterprise Value $M1,835EPS $-0.7Operating Margin %-3,390.6F-Score2
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-3,372.4Higher ROA y-yN
Price/Book9.310-y EBITDA Growth Rate %2.8Quick Ratio12.8Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %32.7Current Ratio12.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-43.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-46.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M82.9ROI % (ttm)-45.4Gross Margin Increase y-yN

Gurus Latest Trades with EXAS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXASPRIMECAP Management 2014-06-30 Buy 0.05%$11.17 - $17.27
($13.72)
$ 24.2877%New holding, 2491300 sh.2,491,300
EXASGeorge Soros 2014-06-30 Sold Out -0.03%$11.17 - $17.27
($13.72)
$ 24.2877%Sold Out0
EXASGeorge Soros 2014-03-31 Buy 0.03%$11.75 - $14.82
($13.45)
$ 24.2880%New holding, 200000 sh.200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXAS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
EXAS PRIMECAP Management 2014-09-302,496,3003.010.05+0.2%
Premium Most recent portfolio changes are included for Premium Members only!


EXAS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LIDGARD GRAHAM PETERChief Science Officer 2014-10-29Sell8,015$24.68-1.62view
CRAWFORD SALLYDirector 2014-10-20Sell83,304$23.493.36view
Conroy Kevin TPresident and CEO 2014-10-20Sell400,000$23.493.36view
ARORA MANEESHCOO 2014-10-20Sell247,500$23.493.36view
LIDGARD GRAHAM PETERChief Science Officer 2014-10-20Sell150,000$23.493.36view
LIDGARD GRAHAM PETERSr. VP, Chief Science Officer 2014-07-25Sell11,081$15.9951.84view
ARORA MANEESHCOO 2014-07-25Sell9,291$15.9951.84view
Conroy Kevin TPresident and CEO 2014-07-25Sell11,336$15.9951.84view
Megan William J.SVP, Finance & PFO 2014-05-05Buy10,000$11.79105.94view
Conroy Kevin TPresident and CEO 2014-02-24Sell8,708$14.0772.57view

Press Releases about EXAS :

    Quarterly/Annual Reports about EXAS:

    News about EXAS:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Exact Sciences Corp Zayo Group Holdings Inc, Western Alliance Bancorp, a Oct 27 2014 
    CEO Kevin T. Conroy of Exact Sciences to Be Interviewed Live on Clear Channel -- iHeart Business Tal Oct 15 2014 
    Meridian Funds Comments on Exact Sciences Corp Jun 20 2014 
    comment on EXAS May 12 2013 
    comment on EXAS May 12 2013 
    comment on EXAS May 12 2013 
    Weekly CEO Buys Highlight: BFS, FL, BGC, AMCF, and EXAS Nov 28 2010 
    EXACT Sciences Corp. (EXAS) CEO Kevin T Conroy buys 6,000 Shares Nov 23 2010 
    EXACT Sciences Corp. (EXAS) CFO Maneesh Arora buys 2,500 Shares Aug 20 2010 
    cooldecency99 note on EXAS May 01 2010 

    More From Our Partners
    Exact Sciences: Caught Between Bulls And Bears Nov 18 2014 - SEEKINGALPHA

    More From Other Websites
    [audio] A fairly valued market may mean gains in 2015 Nov 21 2014
    Cologuard® Wins Popular Science Magazine’s 2014 “Best of What's New” Award Nov 12 2014
    EXACT SCIENCES CORP Financials Nov 06 2014
    American Cancer Society Includes Exact Sciences' Cologuard in Colorectal Cancer Prevention and Early... Nov 06 2014
    American Cancer Society Includes Exact Sciences’ Cologuard in Colorectal Cancer Prevention and... Nov 06 2014
    Exact Sciences to Participate in November Conferences Nov 05 2014
    Exact Sciences to Participate in November Conferences Nov 05 2014
    10-Q for EXACT Sciences Corp. Nov 03 2014
    EXACT SCIENCES CORP Files SEC form 10-Q, Quarterly Report Oct 31 2014
    Exact Sciences Announces Meriter-UnityPoint Health Now Offering Cologuard® Oct 29 2014
    Exact Sciences Announces Meriter-UnityPoint Health Now Offering Cologuard® Oct 29 2014
    Weekly CEO Sells Highlight: Exact Sciences Corp Zayo Group Holdings Inc, Western Alliance ... Oct 27 2014
    Exact Sciences Reports Third-Quarter 2014 Financial Results Oct 27 2014
    Exact Sciences misses 3Q profit forecasts Oct 27 2014
    Exact Sciences misses 3Q profit forecasts Oct 27 2014
    Exact Sciences Reports Third-Quarter 2014 Financial Results Oct 27 2014
    Q3 2014 Exact Sciences Corp Earnings Release - Before Market Open Oct 27 2014
    Exact Sciences Announces MDVIP As The First Network of Personalized Healthcare Physicians To Offer... Oct 22 2014
    Exact Sciences Announces MDVIP As The First Network of Personalized Healthcare Physicians To Offer... Oct 22 2014
    MDVIP Is The First Network of Personalized Healthcare Physicians To Offer Cologuard, A New... Oct 22 2014
    [$$] Exact Sciences CEO Has High Hopes for At-Home Cancer Test Oct 22 2014
    [video] How to Land $400 Million in Funding Oct 21 2014
    Exact Sciences to Host Third-Quarter 2014 Results Webcast and Call Oct 20 2014
    Exact Sciences to Host Third-Quarter 2014 Results Webcast and Call Oct 20 2014
    Regeneron Pharmaceuticals (REGN) Jumps: Stock Up 8.5% Oct 20 2014
    CEO Kevin T. Conroy of Exact Sciences to Be Interviewed Live on Clear Channel -- iHeart Business... Oct 15 2014
    Can the Rally in EXACT Sciences (EXAS) Shares Continue? Oct 15 2014
    UPDATE: Wedbush Reiterates On EXACT Sciences Corporation Following Favorable CMS Coverage And... Oct 13 2014
    Exact Sciences (EXAS) Looks Strong: Stock Surges 35.8% Oct 13 2014
    Exact Sciences soars on colon cancer test ruling Oct 10 2014
    US STOCKS-Wall St falls modestly with Ukraine in focus Aug 12 2014
    US STOCKS-Wall St dips with Ukraine in focus Aug 12 2014
    US STOCKS-Wall St flat amid Ukraine uncertainty Aug 12 2014
    FDA approves first DNA-based test for colon cancer Aug 11 2014
    Exact Sciences Announces FDA Advisory Committee Unanimously Recommends Approval of Cologuard Mar 27 2014
    Exact Sciences' Stock Trading Halted Today; FDA Advisory Committee Meeting to Review Premarket... Mar 27 2014
    Exact Sciences Announces Appointment of Kevin Conroy as Chairman of the Board; David Thompson to... Mar 21 2014
    Exact Sciences' DeeP-C Study Results Published in New England Journal of Medicine Mar 19 2014
    Exact Sciences to Participate in ROTH Conference Mar 03 2014
    Exact Sciences Reports Fourth-Quarter and Full-Year 2013 Financial Results Feb 20 2014
    Exact Sciences to Host Fourth-Quarter 2013 Results Webcast and Call Feb 10 2014
    U.S. Food and Drug Administration confirms date for Exact Sciences' advisory committee Feb 05 2014
    Exact Sciences to participate in Leerink Swann Global Healthcare Conference Feb 04 2014
    Exact Sciences to Participate in J.P. Morgan Healthcare Conference Jan 06 2014
    Exact Sciences Announces Date for FDA Advisory Committee Meeting Dec 03 2013

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK